US2012252050A1PendingUtilityA1
Methods for assessing risk of bone fracture
Est. expiryJun 22, 2024(expired)· nominal 20-yr term from priority
G01N 21/65A61B 5/0075A61B 5/4509G01N 33/68G01R 33/465G01N 2030/8831A61B 5/7275A61B 5/4869G01N 2333/4742A61B 5/6826A61B 5/4504
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention generally relates to methods for assessing risk of bone fracture. In certain embodiments, methods of the invention involve a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal, b) analyzing at least one bone-fracture risk factor associated with the mammal, and c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.
Claims
exact text as granted — not AI-modified1 . A method for assessing risk of bone fracture of a bone of a mammal, the method comprising:
a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal; b) analyzing at least one bone-fracture risk factor associated with the mammal; and c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.
2 . The method according to claim 1 , wherein the assay is performed in situ.
3 . The method according to claim 1 , wherein assay is measuring chemical changes in the tissue.
4 . The method according to claim 3 , wherein the chemical changes in the tissue are changes in levels of sulfur bonding.
5 . The method according to claim 1 , wherein the assay is performed by a technique selected from the group consisting of: Raman spectroscopy; nuclear magnetic resonance spectroscopy; infrared spectroscopy; chiroptical techniques; mass spectrometry; chromatography; and reactions with Elman's reagent.
6 - 7 . (canceled)
8 . The method according to claim 1 , wherein the assay comprises measuring changes in chemical composition of the tissue by a Raman spectroscopy technique.
9 . The method according to claim 8 , wherein the measurement is obtained at a depth of least 50 microns into the tissue.
10 . The method according to claim 8 , further comprising performing a spectral analysis of obtained Raman spectra by multivariate analysis.
11 . The method according to claim 8 , wherein changes in chemical composition of the tissue are changes in levels of sulfur bonding in proteins in the tissue.
12 . The method according to claim 8 , wherein the Raman spectroscopy measures a peak or set of peaks in a 0-4000 cm −1 spectral region.
13 . The method according to claim 8 , wherein the Raman spectroscopy measures a peak selected from the group consisting of: a peak at about 510 cm −1 ; a peak at about 621 cm −1 ; and a peak at about 643 cm −1 .
14 . The method according to claim 1 , wherein the keratinized tissue is selected from the group consisting of: nail; hair; and skin.
15 . The method according to claim 14 , wherein the nail is a clipped finger nail or toe nail.
16 . The method according to claim 15 , wherein the clipped finger nail or toe nail has been archived for a period of time.
17 . The method according to claim 1 , wherein the bone is a hip bone.
18 . The method according to claim 1 , wherein the bone-fracture risk factor is selected from the group consisting of: age, body mass index (BMI), smoking status, thyroid hormone use, diet, age at menopause, alcohol consumption, diagnosis of osteoporosis, and a combination thereof.
19 . The method according to claim 1 , wherein prior to the conducting step, the method further comprises obtaining the keratinized tissue from the mammal.
20 . The method according to claim 1 , wherein the mammal is a human female.
21 . The method according to claim 20 , wherein the female is post-menopausal.
22 . The method according to claim 21 , wherein the female is younger than 65 years of age.
23 . A method for assessing risk of bone fracture of a bone of a mammal, the method comprising:
measuring changes in chemical composition of keratinized tissue by a Raman spectroscopy technique; and comparing obtained Raman spectra to a set of reference spectra, thereby assessing the risk of bone fracture of a bone of the mammal.
24 . The method according to claim 23 , wherein the measurement is obtained at a depth of least 50 microns into the tissue.
25 . The method according to claim 23 , wherein changes in chemical composition of the tissue are changes in levels of sulfur bonding in proteins in the tissue.
26 . The method according to claim 23 , wherein the Raman spectroscopy measures a peak or set of peaks in a 0-4000 cm −1 spectral region.
27 . The method according to claim 23 , wherein the Raman spectroscopy measures a peak selected from the group consisting of: a peak at about 510 cm −1 ; a peak at about 621 cm −1 ; and a peak at about 643 cm −1 .
28 . The method according to claim 23 , wherein the keratinized tissue is selected from the group consisting of: nail; hair; and skin.
29 . The method according to claim 28 , wherein the nail is a clipped finger nail or toe nail.
30 . The method according to claim 29 , wherein the clipped finger nail or toe nail has been archived for a period of time.
31 . The method according to claim 23 , wherein the bone is a hip bone.
32 . The method according to claim 23 , wherein prior to the measuring step, the method further comprises obtaining the keratinized tissue from the mammal.
33 . The method according to claim 23 , wherein the mammal is a human female.
34 . The method according to claim 33 , wherein the female is post-menopausal.
35 . The method according to claim 34 , wherein the female is younger than 65 years of age.
36 . The method according to claim 23 , wherein prior to the performing step, the method further comprises performing a spectral analysis of obtained Raman spectra by multivariate analysis.
37 . The method according to claim 23 , further comprising a spectral analysis of obtained Raman spectra by multivariate analysis.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.